Here's the live share price of Brooks Laboratories along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Over the last 5 years, the share price of Brooks Laboratories has gained 31.65% CAGR. Over the past year, the corresponding return has been 2.77%.
Brooks Laboratories’s current P/E of -1,103.99x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Highest YOY Quarterly profit growth Screener.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
---|---|---|---|---|---|---|---|
Brooks Laboratories | 5.32 | -0.65 | 18.61 | 45.03 | 2.77 | 5.37 | 31.65 |
Sun Pharmaceutical Industries | 1.72 | -0.19 | -4.84 | -2.78 | -12.83 | 21.97 | 26.07 |
Divi's Laboratories | -1.82 | 0.59 | -10.34 | 8.70 | 10.77 | 17.89 | 13.85 |
Cipla | -1.05 | 3.83 | 2.57 | 7.94 | -4.09 | 13.61 | 16.56 |
Torrent Pharmaceuticals | -0.59 | -1.06 | 11.52 | 16.85 | 4.03 | 33.36 | 20.31 |
Dr. Reddy's Laboratories | 3.93 | 6.85 | -3.54 | 16.65 | -1.48 | 15.18 | 8.16 |
Mankind Pharma | 1.32 | 6.71 | 9.33 | 17.63 | 6.84 | 22.22 | 12.79 |
Zydus Lifesciences | 3.16 | 9.26 | 6.67 | 16.01 | -6.13 | 40.48 | 23.06 |
Lupin | 2.61 | 2.25 | -1.85 | 0.69 | -9.91 | 43.63 | 15.52 |
Abbott India | -4.03 | -6.37 | -2.29 | 1.29 | 4.76 | 19.46 | 12.93 |
Alkem Laboratories | 1.67 | 11.36 | 10.35 | 12.92 | -14.03 | 18.95 | 13.22 |
Aurobindo Pharma | 7.19 | 5.40 | -4.35 | 1.70 | -26.38 | 26.29 | 6.69 |
Glenmark Pharmaceuticals | 6.54 | 3.55 | 29.63 | 51.43 | 22.75 | 75.86 | 34.32 |
Biocon | 1.93 | 6.36 | 2.68 | 10.59 | -5.60 | 6.23 | -3.41 |
GlaxoSmithKline Pharmaceuticals | 0.63 | 6.33 | -15.41 | 7.64 | 0.11 | 26.22 | 11.31 |
Laurus Labs | 2.46 | 7.65 | 32.23 | 55.89 | 76.70 | 17.85 | 28.89 |
Anthem Biosciences | -2.73 | 8.94 | 12.41 | 12.41 | 12.41 | 3.98 | 2.37 |
Cohance Lifesciences | 10.87 | 6.03 | -0.50 | -13.73 | -16.31 | 27.94 | 23.52 |
Ipca Laboratories | -2.11 | -2.04 | -5.71 | 1.51 | -8.73 | 14.40 | 5.38 |
Gland Pharma | 4.15 | 1.51 | 16.89 | 22.12 | 4.01 | -5.96 | 1.55 |
Over the last one year, Brooks Laboratories has gained 2.77% compared to peers like Sun Pharmaceutical Industries (-12.83%), Divi's Laboratories (10.77%), Cipla (-4.09%). From a 5 year perspective, Brooks Laboratories has outperformed peers relative to Sun Pharmaceutical Industries (26.07%) and Divi's Laboratories (13.85%).
Day | SMA | EMA |
---|---|---|
5 | 139.24 | 145.76 |
10 | 141.06 | 144.88 |
20 | 147.69 | 146.04 |
50 | 149.23 | 146.3 |
100 | 141.98 | 143.58 |
200 | 142.65 | 139.41 |
In the latest quarter, Brooks Laboratories remained same as its previous close in promoter holding, while DII stake unchanged at 10.38%, FII holding fell to 0.00%, and public shareholding moved up to 37.00% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Date Time | Announcement |
---|---|
Sep 10, 2025, 5:20 PM IST | Brooks Laboratories - Intimation Of Record Date, E-Voting Dates And Book Closure Date |
Sep 05, 2025, 3:18 AM IST | Brooks Laboratories - Letter To The Shareholders - Annual Report For The FY 2024-25. |
Sep 05, 2025, 2:36 AM IST | Brooks Laboratories - Shareholder Meeting- AGM On 26Th September 2025. |
Sep 05, 2025, 2:23 AM IST | Brooks Laboratories - Reg. 34 (1) Annual Report. |
Sep 01, 2025, 5:31 AM IST | Brooks Laboratories - Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association |
Brooks Laboratories Ltd. is a Public Limited Listed company incorporated on 23/01/2002 and has its registered office in the State of Himachal Pradesh, India. Company's Corporate Identification Number(CIN) is L24232HP2002PLC000267 and registration number is 000267. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 82.56 Cr. and Equity Capital is Rs. 29.46 Cr. for the Year ended 31/03/2025.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Brooks Laboratories is ₹152.35 as on Sep 11, 2025.
The Brooks Laboratories is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
The market cap of Brooks Laboratories is ₹448.78 Cr as on Sep 11, 2025.
Today’s highest and lowest price of Brooks Laboratories are ₹158.75 and ₹152.00.
The 52-week high/low is the highest and lowest price at which Brooks Laboratories stock has traded in the past 52-week or nearly a year. The 52-week high of Brooks Laboratories is ₹202.80 and 52-week low of Brooks Laboratories is ₹97.80 as on Sep 11, 2025.
The Brooks Laboratories has shown returns of 0.76% over the past day, -0.65% for the past month, 18.61% over 3 months, 2.77% over 1 year, 5.37% across 3 years, and 31.65% over 5 years.
P/E ratio of and PB ratio of Brooks Laboratories are -1,103.99 and 7.19 on Sep 11, 2025. While the company gives a dividend yield of 0.00 per annum.